New research opens the door for more streamlined and patient-centric protocols, informed by benchmarking analysis of phase II and III protocol procedures The research assesses how protocol design ...
In the early 2000s, Paul Harris, a research informatics faculty member and bioengineer at Vanderbilt University Medical Center, noticed a pressing problem. While working with research teams, he found ...
“End-to-End” Strategies Achieve Better Enrollment, Diversity, and Data Collection in Clinical Trials
The revolution in cancer drug development has a caveat: Only a fraction of eligible patients take part in clinical trials. Historically, findings from studies estimate that the share of eligible ...
A Multicenter Phase II Trial of Ruxolitinib for Treatment of Corticosteroid Refractory Sclerotic Chronic Graft-Versus-Host Disease Strategies to bring clinical trials closer to patients gained ...
Navigating today’s rapidly evolving clinical trial landscape can be tough. With intricate protocols and shifting regulatory demands, it’s more difficult than ever to find and keep participants, as ...
A new tech startup wants to disrupt the clinical trial process and landed $203 million to help scale up its technology. Paradigm, a clinical trials data and patient-matching platform, aims to open up ...
Although over 7% of American adults identify as lesbian, gay, bisexual, transgender, queer, intersex, or asexual (LGBTQIA+), 1 there is a dearth of cancer research in these populations. As such, there ...
Data collection is the process of gathering and measuring information used for research. Collecting data is one of the most important steps in the research process, and is part of all disciplines ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results